42 studies found for:    Open Studies | "Blindness"
Show Display Options
Rank Status Study
21 Recruiting Electro-acupuncture and Transcorneal Electrical Stimulation (TES) for the Treatment of Vision Loss Due to Retinitis Pigmentosa
Condition: Retinitis Pigmentosa
Interventions: Device: Electro-acupuncture;   Device: Laser Acupuncture;   Device: Transcorneal Electrical Stimulation;   Device: Sham Electro-acupuncture;   Device: Sham laser acupuncture;   Device: Sham transcorneal electrical stimulation
22 Recruiting Clinical Trial of Autologous Intravitreal Bone-marrow CD34+ Stem Cells for Retinopathy
Conditions: Dry Age-related Macular Degeneration;   Diabetic Retinopathy;   Retina Vein Occlusion;   Retinitis Pigmentosa;   Hereditary Macular Degeneration
Intervention: Drug: CD34+ bone marrow stem cells intravitreal
23 Recruiting Revacept in Symptomatic Carotid Stenosis (Revacept/CS/02)
Conditions: Carotid Stenosis;   Atherosclerosis;   Stroke;   Transient-ischaemic Attack;   TIA;   Amaurosis Fugax
Interventions: Drug: Revacept;   Drug: Placebo
24 Recruiting Retinal Imaging of Subjects Implanted With Ciliary Neurotrophic Factor (CNTF)-Releasing Encapsulated Cell Implant for Early-stage Retinitis Pigmentosa
Conditions: Retinitis Pigmentosa;   Usher Syndrome Type 2;   Usher Syndrome Type 3
Intervention: Drug: NT-501
25 Unknown  GLP Analogs for Diabetes in Wolfram Syndrome Patients
Conditions: Diabetes Mellitus Associated With Genetic Syndrome;   Wolfram Syndrome
Intervention: Drug: Exenatide
26 Recruiting Natural History and Genetic Studies of Usher Syndrome
Conditions: Retinitis Pigmentosa Syndromic;   Congenital Deafness;   Usher Syndrome;   Retinitis Pigmentosa and Deafness;   Progressive Hearing Loss;   Retinitis Pigmentosa
Intervention:
27 Recruiting Study of UshStat in Patients With Retinitis Pigmentosa Associated With Usher Syndrome Type 1B
Conditions: Usher Syndrome;   Retinitis Pigmentosa
Intervention: Genetic: UshStat
28 Recruiting Clinical and Genetic Examination of Usher Syndrome Patients' Cohort in Europe
Condition: Usher Syndrome
Intervention:
29 Recruiting PDE5 Inhibitor Use and Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)
Condition: Anterior Ischemic Optic Neuropathy
Intervention: Drug: Diagnostic procedures
30 Recruiting Patient Registry of Blind Subjects With Sleep-related Problems
Condition: Sleep-wake Disorder in Blind Individuals
Intervention: Other: Data collection on blindness and sleep problems
31 Recruiting Safety and Effectiveness of 11b-Hydroxysteroid Dehydrogenase Type 1 Inhibitor (AZD4017) to Treat Idiopathic Intracranial Hypertension.
Condition: Idiopathic Intracranial Hypertension
Intervention: Drug: AZD4017
32 Recruiting Safety Study of Tasimelteon for Treatment of Non-24-Hour-Sleep-Wake Disorder in Blind Individuals With No Light Perception
Condition: Non 24 Hour Sleep Wake Disorder
Intervention: Drug: tasimelteon
33 Recruiting Intravitreal LFG316 in Patients With Age-related Macular Degeneration (AMD)
Conditions: Geographic Atrophy;   Age-related Macular Degeneration
Interventions: Drug: LFG316;   Drug: Sham;   Drug: LFG316 Lower dose
34 Recruiting Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
Condition: Non-24-Hour Sleep-Wake Disorder
Intervention: Drug: tasimelteon
35 Recruiting Safety and Efficacy of Subretinal Implants for Partial Restoration of Vision in Blind Patients
Conditions: Retinitis Pigmentosa;   Retinal Degeneration
Intervention: Device: Device name: "Retina Implant model Alpha". Surgical implantation of medical device into eye
36 Recruiting Aflibercept After Ranibizumab in Exudative Age-related Macular Degeneration
Conditions: Macular Degeneration;   Wet Macular Degeneration;   Retinal Degeneration;   Retinal Diseases;   Eye Diseases
Intervention: Drug: Aflibercept
37 Recruiting OZURDEX in Age Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: OZURDEX
38 Unknown  Sub-tenon Triamcinolone Acetonide in Age-Related Macular Degeneration as Adjunct to Ranibizumab
Condition: Wet Macular Degeneration
Interventions: Drug: Ranibizumab;   Drug: Triamcinolone Acetonide
39 Recruiting Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment Outcomes
Condition: Age Related Macular Degeneration
Intervention: Drug: Ranibizumab
40 Recruiting Intra-arterial Thrombolysis for Severe Recent Central Retinal Vein Occlusion
Condition: Central Retinal Vein Occlusion
Intervention: Drug: Tissue Plasminogen Activator

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-42) Show next page of results    Last Page
Indicates status has not been verified in more than two years